Intervention

Escitalopram (Lexapro)

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 4 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials4

Recruiting1

Common conditions6

Lead sponsors shown3

Clinical trials

4 shown

Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive DisorderNCT06692361 · 2025-01-01

RECRUITING

Clinical Pharmacogenomics of Antidepressant ResponseNCT00384020 · 2006-01-01

COMPLETED

Lexapro in the Treatment of Patients With Postpartum DepressionNCT00277108 · 2004-02-01

COMPLETED

Escitalopram Treatment of Patients With Agitated DementiaNCT00260624 · 2003-02-01

COMPLETED

Common conditions

Alzheimer's Disease1 Depression1 Depression - Major Depressive Disorder1 Major Depressive Disorder (MDD)1 Postpartum Depression1 Psychomotor Agitation1

Leading sponsors

University of Rochester 2 Gang Wang 1 National Health Research Institutes, Taiwan 1

Trial status mix

COMPLETED3

RECRUITING1

Phase mix

NA2

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.